DrugPatentWatch Database Preview

VERDESO Drug Profile

Email this page to a colleague

« Back to Dashboard

When do Verdeso patents expire, and when can generic versions of Verdeso launch?

Verdeso is a drug marketed by Almirall and is included in one NDA. There are five patents protecting this drug.

This drug has forty-eight patent family members in twenty-one countries.

The generic ingredient in VERDESO is desonide. There are thirty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the desonide profile page.

US ANDA Litigation and Generic Entry Outlook for Verdeso

A generic version of VERDESO was approved as desonide by TARO on August 3^rd, 1994.

Summary for VERDESO

International Patents:	48
US Patents:	5
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	45
Patent Applications:	4,976
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for VERDESO
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for VERDESO
DailyMed Link:	VERDESO at DailyMed

See drug prices for VERDESO

Recent Litigation for VERDESO

Identify potential future generic entrants

District Court Litigation

Case Name	Date
Delcor Asset Corporation v. Taro Pharmaceutical Industries, Ltd.	2016-03-01
New Century Transportation, Inc.	2014-06-11

See all VERDESO litigation

Pharmacology for VERDESO

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Synonyms for VERDESO

(11ss,16alpha)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione

(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one

(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one

(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one

(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one

11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone

11beta,21-dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione

11beta,21-dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione

11beta,21-dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione

16-alpha-Hydroxyprednisole-16,17-acetonide

16?,17-[1-Methylethylidenebis(oxy)]-11?,21-dihydroxypregna-1,4-diene-3,20-dione

16alpha-hydroxyprednisole-16,17-acetonide

16alpha-hydroxyprednisolone-16alpha,17-acetonide

16alpha,17-[1-Methylethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione (Desonide)

16alpha,17alpha-isopropylidenedioxyprednisolone

638-94-8

638D948

AB01274712_02

AB01274712-01

AB2000229

Apolar

AS-13892

BCP04201

BRD-K21528677-001-03-6

C-22009

CAS-638-94-8

CC-26356

CCG-221279

CHEBI:204734

CHEMBL1201109

CS-2228

D 2083

D-2083

D03696

D2083

DB01260

desfluorotriamcinolone acetonide

Desilux

Desonate

Desonida

Desonida [INN-Spanish]

DESONIDE

Desonide (USAN/INN)

Desonide [USAN:INN:BAN]

Desonidum

Desonidum [INN-Latin]

DesOwen

Desowen (TN)

DSSTox_CID_26756

DSSTox_GSID_46756

DSSTox_RID_81880

DTXSID7046756

EINECS 211-351-6

Flusemidon

GTPL7066

Hamiltoderm

HMS3715P20

HY-B0248

J280872D1O

K016

Locapred

Locapred;Topifug;Tridesilon

NCGC00167983-01

NCGC00274065-01

Prednacinolone

Prednisolone-16,17-acetonide, 16-alpha-hydroxy-

Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-

Prenacid

Q-101382

Q904011

Reticus

s1701

SC-17104

SCHEMBL3631

Sterax

Steroderm

Topifug

Tox21_112603

Tox21_112603_1

Tridesilon

Tridesonit

UNII-J280872D1O

Verdeso (TN)

WBGKWQHBNHJJPZ-LECWWXJVSA-N

ZINC4212851

Zotinar

US Patents and Regulatory Information for VERDESO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Almirall	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006		RX	Yes	Yes			Y
Almirall	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006		RX	Yes	Yes			Y
Almirall	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006		RX	Yes	Yes			Y

Expired US Patents for VERDESO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Almirall	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006
Almirall	VERDESO	desonide	AEROSOL, FOAM;TOPICAL	021978-001	Sep 19, 2006

International Patents for VERDESO

Country	Patent Number	Estimated Expiration
Japan	2008542353
European Patent Office	1796636
Poland	1796636

Supplementary Protection Certificates for VERDESO

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0613371	SPC/GB02/033	United Kingdom		PRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515